James C. Kisicki

Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution

Robert J. Przybelski, Elaine K. Daily, James C. Kisicki et al. · Critical Care Medicine · 1996 · 137 citations

Oral Delivery of Anticoagulant Doses of Heparin

R Baughman, Shiv Kapoor, Rajesh Agarwal et al. · Circulation · 1998 · 129 citations

Febuxostat (TMX‐67), a Novel, Non‐Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

Michael A. Becker, James C. Kisicki, Reza Khosravan et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 96 citations

Molecular Pharmacology, Adverse Events, Urology +15

Pramlintide: A Human Amylin Analogue Reduced Postprandial Plasma Glucose, Insulin, and C-peptide Concentrations in Patients with Type 2 Diabetes

R. Thompson, Alan Gottlieb, K. Organ et al. · Diabetic Medicine · 1997 · 71 citations

Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin

S J Bannister, Vincent P. Houser, James D. Hulse et al. · Acta Psychiatrica Scandinavica · 1989 · 70 citations

Drug Interactions, Medicinal Chemistry, Pharmacological Study +7